Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure.

Virology
F K TreurnichtCarolyn Williamson

Abstract

It is unresolved whether recently transmitted human immunodeficiency viruses (HIV) have genetic features that specifically favour their transmissibility. To identify potential "transmission signatures", we compared 20 full-length HIV-1 subtype C genomes from primary infections, with 66 sampled from ethnically and geographically matched individuals with chronic infections. Controlling for recombination and phylogenetic relatedness, we identified 39 sites at which amino acid frequency spectra differed significantly between groups. These sites were predominantly located within Env, Pol and Gag (14/39, 9/39 and 6/39 respectively) and were significantly clustered (33/39) within known immunoreactive peptides. Within 6 months of infection, we detected reversion-to-consensus mutations at 14 sites and potential CTL escape mutations at seven. Here we provide evidence that frequent reversion mutations probably allows the virus to recover replicative fitness which, together with immune escape driven by the HLA alleles of the new hosts, differentiate sequences from chronic infections from those sampled shortly after transmission.

References

Sep 25, 1992·Nucleic Acids Research·P F Edmonson, J I Mullins
Jan 27, 1999·Bioinformatics·D Posada, K A Crandall
Jan 29, 1999·Journal of Virological Methods·G FangB Weiser
Sep 12, 2000·Bioinformatics·D Martin, E Rybicki
Jan 7, 2004·Nature Reviews. Genetics·Andrew RambautEdward C Holmes
Feb 11, 2004·Nature Medicine·A J LeslieP J R Goulder
Sep 21, 2004·Bioinformatics·D P MartinD Posada
Dec 14, 2004·Nature·Photini KiepielaPhilip J R Goulder
Sep 15, 2005·Bioinformatics·Richard J Edwards, Denis C Shields
Apr 6, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ludo LavreysJulie Overbaugh
May 17, 2006·Journal of Virological Methods·Christine M RousseauJames I Mullins
Aug 10, 2006·Bioinformatics·Konrad SchefflerCathal Seoighe
Sep 15, 2006·Journal of Virology·Livio HeathDarren P Martin
Nov 18, 2006·Bioinformatics·Sergei L Kosakovsky PondSimon D W Frost
May 10, 2007·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Aug 30, 2007·AIDS Research and Human Retroviruses·Nobubelo G NganduUNKNOWN HIVNET028 Study Team
Mar 29, 2008·PLoS Pathogens·Denis R ChoperaUNKNOWN CAPRISA 002 Study Team
Apr 17, 2008·PloS One·Francois van LoggerenbergUNKNOWN CAPRISA 002 Acute Infection Study Team
Apr 23, 2008·The Journal of Experimental Medicine·Paul A GoepfertEric Hunter
Jul 4, 2008·Journal of Virology·Philippa C MatthewsPhilip J R Goulder
Dec 20, 2008·PLoS Pathogens·Wayne DelportCathal Seoighe
Feb 6, 2009·Journal of Virology·M-R AbrahamsUNKNOWN Center for HIV-AIDS Vaccine Immunology Consortium
Jun 3, 2009·The Journal of Experimental Medicine·Nilu GoonetillekeAndrew J McMichael

❮ Previous
Next ❯

Citations

Mar 7, 2012·Future Virology·Denis R ChoperaZabrina L Brumme
Jun 15, 2010·Current Opinion in HIV and AIDS·Brandon F Keele
Sep 8, 2011·Immunology·Deanna A Kulpa, Kathleen L Collins
Jan 15, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Stephanie Jiménez Irausquin, Austin L Hughes
Apr 22, 2011·Virology·Michael M Thomson, Aurora Fernández-García
Jan 24, 2015·Trends in Microbiology·Jonathan M CarlsonZabrina L Brumme
Mar 30, 2019·Current Opinion in HIV and AIDS·Santiago Avila-RiosZabrina L Brumme
Aug 5, 2021·Retrovirology·Sherazaan D IsmailEric J Arts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.